Terms: = Breast cancer AND FANCF, FAF, 2188, ENSG00000183161, Q9NPI8, MGC126856
46 results:
1. Structural Dynamics of P-Rex1 Complexed with Natural Leads Establishes the Protein as an Attractive Target for Therapeutics to Suppress cancer Metastasis.
Hameed AR; Ali SF; Alsallameh SMS; Muhseen ZT; Almansour NM; ALSuhaymi N; Alsugoor MH; Allemailem KS
Biomed Res Int; 2023; 2023():3882081. PubMed ID: 38098889
[TBL] [Abstract] [Full Text] [Related]
2. [The psychological taking charge of the oncological patient: a 3 years study on the activities of psychologists of the Piedmont and Aosta Valley Oncology Network.].
Arduino GM; Zanlungo M; Bertolotti M; Munari J; Stanizzo MR; Laezza A; Piacenza A; Tosco M; Ciofani MG; Carrozzo A; Manfredi M; Sguazzotti E; Peirolo C; Longo M; Castiglia S; Salvino B; Bertetto O
Recenti Prog Med; 2022 Nov; 113(11):674-679. PubMed ID: 36318171
[TBL] [Abstract] [Full Text] [Related]
3. Perceptions Regarding Optimal breast Imaging Education for Radiology Residents: Results of a National Survey.
Winkler N; Braden S; Al-Dulaimi R; Morgan M; Walczak C; Freer P
Curr Probl Diagn Radiol; 2022; 51(4):454-459. PubMed ID: 34561152
[TBL] [Abstract] [Full Text] [Related]
4. Difference in SARS-CoV-2 Antibody Status Between Patients With cancer and Health Care Workers During the COVID-19 Pandemic in Japan.
Yazaki S; Yoshida T; Kojima Y; Yagishita S; Nakahama H; Okinaka K; Matsushita H; Shiotsuka M; Kobayashi O; Iwata S; Narita Y; Ohba A; Takahashi M; Iwasa S; Kobayashi K; Ohe Y; Yoshida T; Hamada A; Doi T; Yamamoto N
JAMA Oncol; 2021 Aug; 7(8):1141-1148. PubMed ID: 34047762
[TBL] [Abstract] [Full Text] [Related]
5. Prevalence of Extrapyramidal Symptoms in cancer Patients Referred to Palliative Care: A Multicenter Observational Study (JORTC PAL12).
Ishiki H; Hamano J; Nagaoka H; Matsuda Y; Tokoro A; Matsuoka H; Izumi H; Sakashita A; Kizawa Y; Oyamada S; Yamaguchi T; Iwase S
Am J Hosp Palliat Care; 2021 Jul; 38(7):823-829. PubMed ID: 32940536
[TBL] [Abstract] [Full Text] [Related]
6. Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment.
Fumet JD; Limagne E; Thibaudin M; Truntzer C; Bertaut A; Rederstorff E; Ghiringhelli F
BMC Cancer; 2020 Aug; 20(1):748. PubMed ID: 32778095
[TBL] [Abstract] [Full Text] [Related]
7. Berunda Polypeptides Carrying Rapalogues Inhibit Tumor mTORC1 Better than Oral Everolimus.
Peddi S; MacKay JA
Biomacromolecules; 2020 Aug; 21(8):3038-3046. PubMed ID: 32484665
[TBL] [Abstract] [Full Text] [Related]
8. Insufficient lymph node assessment in gastric adenocarcinoma.
Khanjani N; Mirzaei S; Nasrolahi H; Hamedi SH; Mosalaei A; Omidvari S; Ahmadloo N; Ansari M; Sobhani F; Mohammadianpanah M
J Egypt Natl Canc Inst; 2019 Oct; 31(1):2. PubMed ID: 32372269
[TBL] [Abstract] [Full Text] [Related]
9. Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research.
Espinosa Fernandez JR; Eckhardt BL; Lee J; Lim B; Pearson T; Seitz RS; Hout DR; Schweitzer BL; Nielsen TJ; Lawrence OR; Wang Y; Rao A; Ueno NT
PLoS One; 2020; 15(4):e0231953. PubMed ID: 32353087
[TBL] [Abstract] [Full Text] [Related]
10. Improvements in visual acuity and macular morphology following cessation of anti-estrogen drugs in a patient with anti-estrogen maculopathy resembling macular telangiectasia type 2: a pathogenic hypothesis.
Shinkai A; Saito W; Hashimoto Y; Ishida S
BMC Ophthalmol; 2019 Dec; 19(1):267. PubMed ID: 31888549
[TBL] [Abstract] [Full Text] [Related]
11. Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/fancf/REV1-mediated DNA damage response.
Lin S; Yu L; Song X; Bi J; Jiang L; Wang Y; He M; Xiao Q; Sun M; Olopade OI; Zhao L; Wei M
Cell Death Dis; 2019 Sep; 10(9):666. PubMed ID: 31511498
[TBL] [Abstract] [Full Text] [Related]
12. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.
Campbell JD; Yau C; Bowlby R; Liu Y; Brennan K; Fan H; Taylor AM; Wang C; Walter V; Akbani R; Byers LA; Creighton CJ; Coarfa C; Shih J; Cherniack AD; Gevaert O; Prunello M; Shen H; Anur P; Chen J; Cheng H; Hayes DN; Bullman S; Pedamallu CS; Ojesina AI; Sadeghi S; Mungall KL; Robertson AG; Benz C; Schultz A; Kanchi RS; Gay CM; Hegde A; Diao L; Wang J; Ma W; Sumazin P; Chiu HS; Chen TW; Gunaratne P; Donehower L; Rader JS; Zuna R; Al-Ahmadie H; Lazar AJ; Flores ER; Tsai KY; Zhou JH; Rustgi AK; Drill E; Shen R; Wong CK; ; Stuart JM; Laird PW; Hoadley KA; Weinstein JN; Peto M; Pickering CR; Chen Z; Van Waes C
Cell Rep; 2018 Apr; 23(1):194-212.e6. PubMed ID: 29617660
[TBL] [Abstract] [Full Text] [Related]
13. The impact of "Be Clear on cancer" campaign on breast care services provided by a specialist oncoplastic unit - A retrospective case control study.
Mazari FAK; Holt S; Azmy IA
Int J Surg; 2017 Nov; 47():54-60. PubMed ID: 28951287
[TBL] [Abstract] [Full Text] [Related]
14. Interpretation of digital breast tomosynthesis: preliminary study on comparison with picture archiving and communication system (PACS) and dedicated workstation.
Kim YS; Chang JM; Yi A; Shin SU; Lee ME; Kim WH; Cho N; Moon WK
Br J Radiol; 2017 Aug; 90(1077):20170182. PubMed ID: 28707529
[TBL] [Abstract] [Full Text] [Related]
15. Network Meta-Analysis on the Effects of DNA Damage Response-Related Gene Mutations on Overall Survival of breast cancer Based on TCGA Database.
Liu C; Chang H; Li XH; Qi YF; Wang JO; Zhang Y; Yang XH
J Cell Biochem; 2017 Dec; 118(12):4728-4734. PubMed ID: 28513990
[TBL] [Abstract] [Full Text] [Related]
16. [Zinc-modified Nanotransporter for Target Drug Therapy of breast cancer].
Skaličková S; Gargulák M; Löffelmann M; Ruttkay-Nedecký B; Kepinská M; Parák T; Kizek R
Klin Onkol; 2017; 30(Supplementum1):174-176. PubMed ID: 28471199
[TBL] [Abstract] [Full Text] [Related]
17. Sentinel Lymph Node Frozen-Section Utilization Declines After Publication of American College of Surgeons Oncology Group Z0011 Trial Results With No Change in Subsequent Surgery for Axillary Lymph Node Dissection.
Jorns JM; Kidwell KM
Am J Clin Pathol; 2016 Jul; 146(1):57-66. PubMed ID: 27373347
[TBL] [Abstract] [Full Text] [Related]
18. Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients.
Ring BZ; Hout DR; Morris SW; Lawrence K; Schweitzer BL; Bailey DB; Lehmann BD; Pietenpol JA; Seitz RS
BMC Cancer; 2016 Feb; 16():143. PubMed ID: 26908167
[TBL] [Abstract] [Full Text] [Related]
19. Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer.
Farolfi A; Scarpi E; Rocca A; Mangia A; Biglia N; Gianni L; Tienghi A; Valerio MR; Gasparini G; Amaducci L; Faedi M; Baldini E; Rubagotti A; Maltoni R; Paradiso A; Amadori D
Eur J Cancer; 2015 Sep; 51(14):1874-81. PubMed ID: 26206258
[TBL] [Abstract] [Full Text] [Related]
20. The Functionality Assessment Flowchart (faf): a new simple and reliable method to measure performance status with a high percentage of agreement between observers.
Paiva CE; Siquelli FA; Santos HA; Costa MM; Massaro DR; Lacerda DC; Nunes JS; de Pádua Souza C; Paiva BS
BMC Cancer; 2015 Jul; 15():501. PubMed ID: 26142726
[TBL] [Abstract] [Full Text] [Related]
[Next]
